 | • レポートコード：MRC2012B0907 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腫瘍治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍治療薬の種類別市場規模（化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、その他）、用途別市場規模（血液がん、乳がん、消化器がん、前立腺がん、呼吸器がん/がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Pfizer、Bristol-Myers Squibb、Celgene、AstraZeneca、Novartis、Eli Lilly、Merck & Co.、Johnson & Johnson、Amgen、Sanofi、Teva、AbbVie、Eisai、Bayer、Ipsen、Takeda、Otsuka、Biogen Idec、Astellas、Merck KGaA、Gilead Sciences、 ・地域別グローバル市場分析 2015年-2020年 ・腫瘍治療薬の北米市場（アメリカ、カナダ、メキシコ） ・腫瘍治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍治療薬の南米市場（ブラジル、アルゼンチン） ・腫瘍治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、その他 ・用途別分析：血液がん、乳がん、消化器がん、前立腺がん、呼吸器がん/がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Oncology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 241150 million by 2025, from USD 165680 million in 2019.
Market segmentation
Oncology Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncology Drugs market has been segmented into:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
By Application, Oncology Drugs has been segmented into:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Oncology Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncology Drugs Market Share Analysis
Oncology Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncology Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Oncology Drugs are:
Roche
Pfizer
Bristol-Myers Squibb
Celgene
AstraZeneca
Novartis
Eli Lilly
Merck & Co.
Johnson & Johnson
Amgen
Sanofi
Teva
AbbVie
Eisai
Bayer
Ipsen
Takeda
Otsuka
Biogen Idec
Astellas
Merck KGaA
Gilead Sciences
Among other players domestic and global, Oncology Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Oncology Drugs Market Overview
1.1 Product Overview and Scope of Oncology Drugs
1.2 Classification of Oncology Drugs by Type
1.2.1 Global Oncology Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oncology Drugs Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy (Biologic Therapy)
1.2.6 Hormonal Therapy
1.2.7 Others
1.3 Global Oncology Drugs Market by Application
1.3.1 Overview: Global Oncology Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Global Oncology Drugs Market by Regions
1.4.1 Global Oncology Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oncology Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncology Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncology Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncology Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business
2.4.3 Celgene SWOT Analysis
2.4.4 Celgene Product and Services
2.4.5 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Product and Services
2.6.4 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Product and Services
2.7.4 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck & Co.
2.8.1 Merck & Co. Details
2.8.2 Merck & Co. Major Business
2.8.3 Merck & Co. Product and Services
2.8.4 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Product and Services
2.9.4 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Product and Services
2.10.4 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Product and Services
2.11.4 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Product and Services
2.12.4 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Product and Services
2.13.4 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eisai
2.14.1 Eisai Details
2.14.2 Eisai Major Business
2.14.3 Eisai Product and Services
2.14.4 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Product and Services
2.15.4 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.16 Ipsen
2.16.1 Ipsen Details
2.16.2 Ipsen Major Business
2.16.3 Ipsen Product and Services
2.16.4 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.17 Takeda
2.17.1 Takeda Details
2.17.2 Takeda Major Business
2.17.3 Takeda Product and Services
2.17.4 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Product and Services
2.18.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.19 Biogen Idec
2.19.1 Biogen Idec Details
2.19.2 Biogen Idec Major Business
2.19.3 Biogen Idec Product and Services
2.19.4 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.20 Astellas
2.20.1 Astellas Details
2.20.2 Astellas Major Business
2.20.3 Astellas Product and Services
2.20.4 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.21 Merck KGaA
2.21.1 Merck KGaA Details
2.21.2 Merck KGaA Major Business
2.21.3 Merck KGaA Product and Services
2.21.4 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Product and Services
2.22.4 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oncology Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Drugs Players Market Share
3.2.2 Top 10 Oncology Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oncology Drugs Revenue and Market Share by Regions
4.2 North America Oncology Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Oncology Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncology Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Oncology Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncology Drugs Revenue and Growth Rate (2015-2020)
5 North America Oncology Drugs Revenue by Countries
5.1 North America Oncology Drugs Revenue by Countries (2015-2020)
5.2 USA Oncology Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Oncology Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Oncology Drugs Revenue and Growth Rate (2015-2020)
6 Europe Oncology Drugs Revenue by Countries
6.1 Europe Oncology Drugs Revenue by Countries (2015-2020)
6.2 Germany Oncology Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Oncology Drugs Revenue and Growth Rate (2015-2020)
6.4 France Oncology Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Oncology Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Oncology Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oncology Drugs Revenue by Countries
7.1 Asia-Pacific Oncology Drugs Revenue by Countries (2015-2020)
7.2 China Oncology Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Oncology Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Oncology Drugs Revenue and Growth Rate (2015-2020)
7.5 India Oncology Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oncology Drugs Revenue and Growth Rate (2015-2020)
8 South America Oncology Drugs Revenue by Countries
8.1 South America Oncology Drugs Revenue by Countries (2015-2020)
8.2 Brazil Oncology Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Oncology Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oncology Drugs by Countries
9.1 Middle East & Africa Oncology Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oncology Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Oncology Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Oncology Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Oncology Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oncology Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Oncology Drugs Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Targeted Therapy Revenue Growth Rate (2015-2025)
10.5 Immunotherapy (Biologic Therapy) Revenue Growth Rate (2015-2025)
10.6 Hormonal Therapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Oncology Drugs Market Segment by Application
11.1 Global Oncology Drugs Revenue Market Share by Application (2015-2020)
11.2 Oncology Drugs Market Forecast by Application (2019-2024)
11.3 Blood Cancer Revenue Growth (2015-2020)
11.4 Breast Cancer Revenue Growth (2015-2020)
11.5 Gastrointestinal Cancer Revenue Growth (2015-2020)
11.6 Prostate Cancer Revenue Growth (2015-2020)
11.7 Respiratory or Lung Cancer Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Oncology Drugs Market Size Forecast (2021-2025)
12.1 Global Oncology Drugs Market Size Forecast (2021-2025)
12.2 Global Oncology Drugs Market Forecast by Regions (2021-2025)
12.3 North America Oncology Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Oncology Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oncology Drugs Revenue Market Forecast (2021-2025)
12.6 South America Oncology Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oncology Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Oncology Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oncology Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Oncology Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Corporate Information, Location and Competitors
Table 7. Roche Oncology Drugs Major Business
Table 8. Roche Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Roche SWOT Analysis
Table 10. Roche Oncology Drugs Product and Solutions
Table 11. Roche Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Pfizer Corporate Information, Location and Competitors
Table 13. Pfizer Oncology Drugs Major Business
Table 14. Pfizer Oncology Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Pfizer SWOT Analysis
Table 16. Pfizer Oncology Drugs Product and Solutions
Table 17. Pfizer Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 19. Bristol-Myers Squibb Oncology Drugs Major Business
Table 20. Bristol-Myers Squibb Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Bristol-Myers Squibb SWOT Analysis
Table 22. Bristol-Myers Squibb Oncology Drugs Product and Solutions
Table 23. Bristol-Myers Squibb Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Celgene Corporate Information, Location and Competitors
Table 25. Celgene Oncology Drugs Major Business
Table 26. Celgene Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Celgene SWOT Analysis
Table 28. Celgene Oncology Drugs Product and Solutions
Table 29. Celgene Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AstraZeneca Corporate Information, Location and Competitors
Table 31. AstraZeneca Oncology Drugs Major Business
Table 32. AstraZeneca Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 33. AstraZeneca SWOT Analysis
Table 34. AstraZeneca Oncology Drugs Product and Solutions
Table 35. AstraZeneca Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Novartis Corporate Information, Location and Competitors
Table 37. Novartis Oncology Drugs Major Business
Table 38. Novartis Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Novartis SWOT Analysis
Table 40. Novartis Oncology Drugs Product and Solutions
Table 41. Novartis Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Eli Lilly Corporate Information, Location and Competitors
Table 43. Eli Lilly Oncology Drugs Major Business
Table 44. Eli Lilly Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Eli Lilly SWOT Analysis
Table 46. Eli Lilly Oncology Drugs Product and Solutions
Table 47. Eli Lilly Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Merck & Co. Corporate Information, Location and Competitors
Table 49. Merck & Co. Oncology Drugs Major Business
Table 50. Merck & Co. Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Merck & Co. SWOT Analysis
Table 52. Merck & Co. Oncology Drugs Product and Solutions
Table 53. Merck & Co. Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Johnson & Johnson Corporate Information, Location and Competitors
Table 55. Johnson & Johnson Oncology Drugs Major Business
Table 56. Johnson & Johnson Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Johnson & Johnson SWOT Analysis
Table 58. Johnson & Johnson Oncology Drugs Product and Solutions
Table 59. Johnson & Johnson Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Amgen Corporate Information, Location and Competitors
Table 61. Amgen Oncology Drugs Major Business
Table 62. Amgen Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 63. Amgen SWOT Analysis
Table 64. Amgen Oncology Drugs Product and Solutions
Table 65. Amgen Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Sanofi Corporate Information, Location and Competitors
Table 67. Sanofi Oncology Drugs Major Business
Table 68. Sanofi Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 69. Sanofi SWOT Analysis
Table 70. Sanofi Oncology Drugs Product and Solutions
Table 71. Sanofi Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Teva Corporate Information, Location and Competitors
Table 73. Teva Oncology Drugs Major Business
Table 74. Teva Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Teva SWOT Analysis
Table 76. Teva Oncology Drugs Product and Solutions
Table 77. Teva Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. AbbVie Corporate Information, Location and Competitors
Table 79. AbbVie Oncology Drugs Major Business
Table 80. AbbVie Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 81. AbbVie SWOT Analysis
Table 82. AbbVie Oncology Drugs Product and Solutions
Table 83. AbbVie Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Eisai Corporate Information, Location and Competitors
Table 85. Eisai Oncology Drugs Major Business
Table 86. Eisai Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 87. Eisai SWOT Analysis
Table 88. Eisai Oncology Drugs Product and Solutions
Table 89. Eisai Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Bayer Corporate Information, Location and Competitors
Table 91. Bayer Oncology Drugs Major Business
Table 92. Bayer Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 93. Bayer SWOT Analysis
Table 94. Bayer Oncology Drugs Product and Solutions
Table 95. Bayer Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Ipsen Corporate Information, Location and Competitors
Table 97. Ipsen Oncology Drugs Major Business
Table 98. Ipsen Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 99. Ipsen SWOT Analysis
Table 100. Ipsen Oncology Drugs Product and Solutions
Table 101. Ipsen Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Takeda Corporate Information, Location and Competitors
Table 103. Takeda Oncology Drugs Major Business
Table 104. Takeda Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 105. Takeda SWOT Analysis
Table 106. Takeda Oncology Drugs Product and Solutions
Table 107. Takeda Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Otsuka Oncology Drugs Type and Application
Table 109. Otsuka Oncology Drugs Major Business
Table 110. Otsuka Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 111. Otsuka SWOT Analysis
Table 112. Otsuka Oncology Drugs Product and Solutions
Table 113. Otsuka Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Biogen Idec Corporate Information, Location and Competitors
Table 115. Biogen Idec Oncology Drugs Major Business
Table 116. Biogen Idec Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 117. Biogen Idec SWOT Analysis
Table 118. Biogen Idec Oncology Drugs Product and Solutions
Table 119. Biogen Idec Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Astellas Corporate Information, Location and Competitors
Table 121. Astellas Oncology Drugs Major Business
Table 122. Astellas Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 123. Astellas SWOT Analysis
Table 124. Astellas Oncology Drugs Product and Solutions
Table 125. Astellas Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Merck KGaA Corporate Information, Location and Competitors
Table 127. Merck KGaA Oncology Drugs Major Business
Table 128. Merck KGaA Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 129. Merck KGaA SWOT Analysis
Table 130. Merck KGaA Oncology Drugs Product and Solutions
Table 131. Merck KGaA Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Gilead Sciences Corporate Information, Location and Competitors
Table 133. Gilead Sciences Oncology Drugs Major Business
Table 134. Gilead Sciences Oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 135. Gilead Sciences SWOT Analysis
Table 136. Gilead Sciences Oncology Drugs Product and Solutions
Table 137. Gilead Sciences Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. Global Oncology Drugs Revenue (Million USD) by Players (2015-2020)
Table 139. Global Oncology Drugs Revenue Share by Players (2015-2020)
Table 140. Global Oncology Drugs Revenue (Million USD) by Regions (2015-2020)
Table 141. Global Oncology Drugs Revenue Market Share by Regions (2015-2020)
Table 142. North America Oncology Drugs Revenue by Countries (2015-2020)
Table 143. North America Oncology Drugs Revenue Market Share by Countries (2015-2020)
Table 144. Europe Oncology Drugs Revenue (Million USD) by Countries (2015-2020)
Table 145. Asia-Pacific Oncology Drugs Revenue (Million USD) by Countries (2015-2020)
Table 146. South America Oncology Drugs Revenue by Countries (2015-2020)
Table 147. South America Oncology Drugs Revenue Market Share by Countries (2015-2020)
Table 148. Middle East and Africa Oncology Drugs Revenue (Million USD) by Countries (2015-2020)
Table 149. Middle East and Africa Oncology Drugs Revenue Market Share by Countries (2015-2020)
Table 150. Global Oncology Drugs Revenue (Million USD) by Type (2015-2020)
Table 151. Global Oncology Drugs Revenue Share by Type (2015-2020)
Table 152. Global Oncology Drugs Revenue Forecast by Type (2021-2025)
Table 153. Global Oncology Drugs Revenue by Application (2015-2020)
Table 154. Global Oncology Drugs Revenue Share by Application (2015-2020)
Table 155. Global Oncology Drugs Revenue Forecast by Application (2021-2025)
Table 156. Global Oncology Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oncology Drugs Picture
Figure 2. Global Oncology Drugs Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Targeted Therapy Picture
Figure 5. Immunotherapy (Biologic Therapy) Picture
Figure 6. Hormonal Therapy Picture
Figure 7. Others Picture
Figure 8. Oncology Drugs Revenue Market Share by Application in 2019
Figure 9. Blood Cancer Picture
Figure 10. Breast Cancer Picture
Figure 11. Gastrointestinal Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Respiratory or Lung Cancer Picture
Figure 14. Others Picture
Figure 15. Global Oncology Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Oncology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Oncology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Oncology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Oncology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Oncology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Oncology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Oncology Drugs Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Oncology Drugs Revenue Market Share in 2019
Figure 24. Global Top 10 Players Oncology Drugs Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Oncology Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Oncology Drugs Revenue Market Share by Regions (2015-2020)
Figure 28. Global Oncology Drugs Revenue Market Share by Regions in 2018
Figure 29. North America Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Europe Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 32. South America Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 34. North America Oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. North America Oncology Drugs Revenue Market Share by Countries in 2019
Figure 36. USA Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Canada Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Europe Oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Oncology Drugs Revenue Market Share by Countries in 2019
Figure 41. Germany Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 42. UK Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 43. France Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Russia Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Italy Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Oncology Drugs Revenue Market Share by Countries in 2019
Figure 48. China Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Japan Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Korea Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 51. India Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 53. South America Oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. South America Oncology Drugs Revenue Market Share by Countries in 2019
Figure 55. Brazil Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Oncology Drugs Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 60. UAE Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Oncology Drugs Revenue and Growth Rate (2015-2020)
Figure 63. Global Oncology Drugs Revenue Share by Type (2015-2020)
Figure 64. Global Oncology Drugs Revenue Share by Type in 2019
Figure 65. Global Oncology Drugs Market Share Forecast by Type (2021-2025)
Figure 66. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 67. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Immunotherapy (Biologic Therapy) Revenue Growth Rate (2015-2020)
Figure 69. Global Hormonal Therapy Revenue Growth Rate (2015-2020)
Figure 70. Global Others Revenue Growth Rate (2015-2020)
Figure 71. Global Oncology Drugs Revenue Share by Application (2015-2020)
Figure 72. Global Oncology Drugs Revenue Share by Application in 2019
Figure 73. Global Oncology Drugs Market Share Forecast by Application (2021-2025)
Figure 74. Global Blood Cancer Revenue Growth Rate (2015-2020)
Figure 75. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 76. Global Gastrointestinal Cancer Revenue Growth Rate (2015-2020)
Figure 77. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 78. Global Respiratory or Lung Cancer Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Oncology Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Oncology Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Oncology Drugs Revenue Market Forecast (2021-2025)
Figure 84. Europe Oncology Drugs Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Oncology Drugs Revenue Market Forecast (2021-2025)
Figure 86. South America Oncology Drugs Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Oncology Drugs Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
腫瘍学/がん治療薬の世界市場（～2026年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastroint…- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
- 整形外科腫瘍学の世界市場（～2026年） Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours. Market Analysis and Insights: Global Orthopaedic Oncology Market The global Orthopaedic Oncology market size is projected to reach US$ XX million by 2…
- 精巣腫瘍治療薬の世界市場（～2026年） Market Analysis and Insights: Global Testicular Cancer Drugs Market The global Testicular Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Testicular Cancer Drugs Scope and Market Size Testicular Cancer Dru…
- 腫瘍栄養学の世界市場（～2026年） Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease ori…